BMN165 20mg/day
165-302
Phase 3 small_molecule completed
Quick answer
BMN165 20mg/day for Phenylketonuria (PKU) is a Phase 3 program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOMARIN PHARMACEUTICAL INC
- Indication
- Phenylketonuria (PKU)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed